The next board meeting for Zevra Therapeutics Inc is on 08 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
Zevra Therapeutics Inc has a share price target of US$ 23, revenue growth forecast of 327.9%, and profit growth estimate of 166.6% for FY25, based on top 8 analyst calls.